In vitro elution of analgesic medications from an absorbable gelatin sponge

dc.contributor.authorBaker, Steven Gerald
dc.date.accessioned2011-05-06T19:00:32Z
dc.date.available2011-05-06T19:00:32Z
dc.date.graduationmonthMayen_US
dc.date.issued2011-05-06
dc.date.published2011en_US
dc.description.abstractObjective: To compare the in vitro elution characteristics of six common analgesic medications from a commercially available absorbable gelatin sponge. Study Design: Experimental study. Methods: Gelatin sponges were loaded with various analgesic medications, including two opioids, preservative-free morphine and fentanyl, two local anesthestics, bupivacaine and lidocaine, and two α2-adrenergic agonists, dexmedetomidine and xylazine. The loaded sponges were placed in dishes containing phosphate-buffered saline (PBS) and maintained at 37° C with constant agitation. Concentrations of each drug were determined at various time points up to 24 hours post-inoculation using high-pressure liquid chromatography. Two phases were conducted, utilizing undried loaded sponges (phase one) and dried loaded sponges (phase two). Results: In both phases, all analgesic medications eluted from the gelatin sponge and equilibrated rapidly with the PBS, achieving maximal concentration within 30 minutes. In phase two, the rapid nature of the release was captured by increasing sampling within the initial 30 minutes. Results were consistent for each medication with minimal variation. Steady state concentrations were significantly higher in phase two with four out of six medications. Conclusions: Analgesic medication elution from an absorbable gelatin sponge was rapid and consistent. Drying the loaded sponge prior to use will likely substantially increase the amount of medication eluted but not prolong release. Clinical Relevance: The rapid release of analgesic medications from the gelatin sponge makes a prolonged analgesic effect unlikely without further modification. Toxicity may be a concern. Further study is required to investigate efficacy in vivo, safe dosing regimens and prolongation of duration of action.en_US
dc.description.advisorWalter C. Renbergen_US
dc.description.degreeMaster of Scienceen_US
dc.description.departmentDepartment of Clinical Sciencesen_US
dc.description.levelMastersen_US
dc.description.sponsorshipNovartis Animal Healthen_US
dc.identifier.urihttp://hdl.handle.net/2097/8790
dc.language.isoen_USen_US
dc.publisherKansas State Universityen
dc.subjectdrug elutionen_US
dc.subjectregional analgesiaen_US
dc.subject.umiVeterinary Medicine (0778)en_US
dc.titleIn vitro elution of analgesic medications from an absorbable gelatin spongeen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
StevenBaker2011.pdf
Size:
722.76 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description: